These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8014501)

  • 21. Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group.
    Donegan E; Busch MP; Galleshaw JA; Shaw GM; Mosley JW
    Ann Intern Med; 1990 Oct; 113(7):555-6. PubMed ID: 2393211
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL; Foster GA; Dodd RY
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of human T lymphotropic virus type by polymerase chain reaction and correlation with risk factors in northern California blood donors.
    Eble BE; Busch MP; Guiltinan AM; Khayam-Bashi H; Murphy EL
    J Infect Dis; 1993 Apr; 167(4):954-7. PubMed ID: 8450261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK; Bhatti FA; Salamat N
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection.
    Zaaijer HL; Cuypers HT; Dudok de Wit C; Lelie PN
    Transfusion; 1994 Oct; 34(10):877-80. PubMed ID: 7940659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
    Dezzutti CS; Guenthner PC; Daniel S; Utz U; Cabrera T; Marshall JH; Bianco C; Lal RB; Cowan EP
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
    Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a supersensitive polymerase chain reaction method for human T lymphotropic virus type II (HTLV-II) and detection of HTLV-II proviral DNA from blood donors in Japan.
    Hamakado T; Matsumoto T; Koyanagi Y; Hayashi K; Fukada K; Kouchiyama T; Yoshida T; Yamamoto N
    Virus Genes; 1992 Apr; 6(2):119-29. PubMed ID: 1589961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.
    Schreiber GB; Murphy EL; Horton JA; Wright DJ; Garfein R; Chien HC; Nass CC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):263-71. PubMed ID: 9117460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion-associated transmission of human T-lymphotropic virus types I and II: experience of a regional blood center.
    Herr V; Ambruso D; Fairfax M; Neumann A; Swanson P; Lee H
    Transfusion; 1993 Mar; 33(3):208-11. PubMed ID: 8438220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-II in blood donors at the Blood Center Net of Ceará - HEMOCE.
    Gomes FV; Eleutério Junior J
    Rev Assoc Med Bras (1992); 2011; 57(3):309-12. PubMed ID: 21691695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of HTLV-I/II in Argentina: an overview.
    Gastaldello R; Hall WW; Gallego S
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):301-8. PubMed ID: 15076246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
    Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
    J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a new third-generation ARCHITECT rHTLV-I/II assay for blood screening and diagnosis.
    Kapprell HP; Stieler M; Oer M; Goller A; Hausmann M; Schochetman G; Devare SG; Qiu X
    Diagn Microbiol Infect Dis; 2010 May; 67(1):61-9. PubMed ID: 20227221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.